Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia-Reference-Cited by-同舟云学术

Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia

Published:1988-10 Issue:2-3 Volume:73 Page:135-141
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Leren Trond P.,Hjermann Ingvar,Berg Kåre,Leren Paul,Foss Olav P.,Viksmoen Lars

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. The Hyperlipoproteinemias — Clinical and Laboratory Practice;Lewis,1976

2. Treatment of hypercholesterolemia;Kane,1982

3. A receptor-mediated pathway for cholesterol homeostasis;Brown;Science,1986

4. Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism;Shepherd;N. Engl. J. Med.,1980

5. Mevinolin and colestipol stimulate receptormediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes;Bilheimer,1983

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherosclerosis: Cholesterol Management;Burger's Medicinal Chemistry and Drug Discovery;2021-04-22

2. Atherosclerosis I : LDL Cholesterol Lowering;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15

3. Use of Lipid‐Lowering Agents in the Prevention of Cardiovascular Disease;Evidence‐Based Cardiology;2009-11-13

4. Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract;Current Pharmaceutical Design;2009-02-01

5. Emerging antidyslipidemic drugs;Expert Opinion on Emerging Drugs;2008-06